TXMD — TherapeuticsMD, Inc.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 25743 ·
Last close
$1.81
Market Cap
$20.95M
52W High
$2.95
52W Low
$1.43
ADV30
21,132
Next earnings
—
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally. Its products portfolio includes IMVEXXY for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause; BIJUVA to treat moderate-to-severe vasomotor symptoms due to menopause in women with a uterus; and ANNOVERA, a ring-shaped contraceptive vaginal system. The company also offers prescription prenatal vitamin products under the BocaGreenMD and vitaMedMD brand names. It has a license agreement with Mayne Pharma Group Limited. The company sells its products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 1,259,000 — -479,000 491,000 37,932,000 10,447,000 10,308,000
Jun 2026 — — — — — — —
Mar 2026 724,000 — -723,000 95,000 37,581,000 8,419,000 10,608,000
Dec 2025 893,000 — -1,496,000 -619,000 37,656,000 7,483,000 10,780,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$2,699,000
Investing CF
—
Financing CF
—
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.08
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-952,296,000
Inventory
—
Receivables
$3,870,000
ST Investments
—
EBIT TTM
$-4,271,000
Pretax Income TTM
$118,000
Interest Exp TTM
$7,000
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$3,270,000
EBITDA
$-1,369,000
Free Cash Flow
$896,625
Enterprise Value
$18,015,056
Total Cash
$9,189,000
Total Debt
$5,560,000
Shares Out
11,574,362
Trailing EPS
$-0.04
Book Value
$2.32
ROE
-1.1%
ROA
-2.9%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 3,022,000 -4,214,000 -569,000 37,656,000 10,780,000 26,876,000 2,454,000
Dec 2024 1,761,000 -4,844,000 -2,181,000 38,822,000 11,452,000 27,370,000 1,170,000
Dec 2023 1,302,000 -8,523,000 -10,278,000 43,309,000 14,022,000 29,287,000 -23,081,000
Dec 2022 69,963,000 10,663,000 111,997,000 90,458,000 55,315,000 35,143,000 9,359,000
Dec 2021 — — — — — — —

TTM Snapshot

Revenues TTM
$3,270,000
NetIncome TTM
$-217,000
OpCashFlow TTM
—
Assets (Latest)
$37,529,000
Forward EPS
$0.35

Max Pain — expiry 2027-03-19 (volume-derived — Yahoo OI feed degraded)

max pain strike: $1.00 · spot: $1.81 · call volume: 28 · put volume: 1

Peers — same industry

TickerNameMarket CapLastDaily %
EDSA Edesa Biotech, Inc. $20.97M $2.17 —
CPHI CHINA PHARMA HOLDINGS, INC. $21.68M $0.50 —
CRVO CervoMed Inc. $20.11M $1.33 —
IXHL Incannex Healthcare Inc. $21.83M $1.74 —
AARD Aardvark Therapeutics, Inc. $21.89M $1.00 —

News headlines (Yahoo Finance, 1h cache)

TherapeuticsMD: Q3 Earnings Snapshot
2026-11-13 21:25 · Yahoo
TherapeuticsMD Announces Third Quarter 2026 Financial Results
2026-11-13 21:05 · Yahoo
TherapeuticsMD Announces Second Quarter 2026 Financial Results
2026-08-11 20:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.